Dynamics of abdominal symptoms during the start of a new therapy with elexacaftor/tezacaftor/ivacaftor using the novel CFAbd-day2day questionnaire by Jochen G. Mainz, Jochen G. Mainz, Anton Barucha, Anton Barucha, Pu Huang, Pu Huang, Lilith Bechinger, Lilith Bechinger, Franziska Duckstein, Franziska Duckstein, Louise Polte, Louise Polte, Pauline Sadrieh, Pauline Sadrieh, Lutz Nährlich, Olaf Eickmeier, Suzanne Van Dullemen, Patience Eschenhagen, Carsten Schwarz, Stefan Lüth, Carlos Zagoya, Carlos Zagoya, Ute Graepler-Mainka

Get full text